NM_001014.5:c.493C>T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_001014.5(RPS10):c.493C>T(p.Gln165*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001014.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS10 | NM_001014.5 | c.493C>T | p.Gln165* | stop_gained | Exon 6 of 6 | ENST00000648437.1 | NP_001005.1 | |
RPS10 | NM_001203245.3 | c.493C>T | p.Gln165* | stop_gained | Exon 6 of 6 | NP_001190174.1 | ||
RPS10 | NM_001204091.2 | c.493C>T | p.Gln165* | stop_gained | Exon 6 of 6 | NP_001191020.1 | ||
RPS10-NUDT3 | NM_001202470.3 | c.456+858C>T | intron_variant | Intron 5 of 8 | NP_001189399.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS10 | ENST00000648437.1 | c.493C>T | p.Gln165* | stop_gained | Exon 6 of 6 | NM_001014.5 | ENSP00000497917.1 | |||
RPS10-NUDT3 | ENST00000639725.1 | c.456+858C>T | intron_variant | Intron 5 of 8 | 5 | ENSP00000492441.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460068Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726372
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.